ADPT
|Adaptive Biotechnologies Corp
NASDAQ
USD 10.09
+0.22|+2.23%
Current Price
USD 10.09
Change
+USD 0.22 (2.23%)
P/E Ratio
Dividend Yield
Market Cap
1.50B
Volume
1.06M
Open
USD 10.04
Previous Close
USD 9.87
52-Week High
USD 10.37
52-Week Low
USD 2.99
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a pat...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Chad M. Robins M.B.A.
Employees:619
Headquarters:Seattle, USA
Website:www.adaptivebiotech.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions